BioCryst Pharmaceuticals | I Saldi



Sales Cambiamento Data
Alnylam Pharmaceuticals USD 773.69M 179.5M 2025-06
Chugai Pharma JPY 290B 1.54B 2025-06
Daiichi Sankyo JPY 474.6B 44.09B 2025-06
DBV Technologies USD 1.46M 712K 2025-06
Gilead Sciences USD 7.1B 430M 2025-06
GlaxoSmithKline GBP 7.99B 470M 2025-06
Glaxosmithkline GBP 7.99B 131M 2025-06
Incyte USD 1.06B 10M 2025-06
Ionis Pharmaceuticals USD 452M 320M 2025-06
Neurocrine Biosciences USD 687.5M 114.9M 2025-06
PTC Therapeutics USD 178.9M 11.1M 2025-06
Regeneron Pharmaceuticals USD 3.68B 650M 2025-06
Roche Holding CHF 31.64B 883M 2024-12
Sarepta Therapeutics USD 611.09M 163.81M 2025-06
Ultragenyx Pharmaceutical USD 166.5M 27.21M 2025-06
Vertex Pharmaceuticals USD 2.96B 190M 2025-06


BioCryst Pharmaceuticals I Saldi - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Sep 2025.